Supplementary Fig 10 from Ligand-Blocking and Agonist Antibodies Targeting TNFR2 Use Distinct Modes of Action to Induce Antitumor Immunity
Authors:
- Linda MårtenssonLMLinda Mårtensson
- Petra HolmkvistPHPetra Holmkvist
- Kirstie L. ClearyKCKirstie L. Cleary
- Carolin SvenssonCSCarolin Svensson
- Monika SemmrichMSMonika Semmrich
- Niyaz YoosufNYNiyaz Yoosuf
- Alexandra Gabriela FerreiraAFAlexandra Gabriela Ferreira
- Mathilda KovacekMKMathilda Kovacek
- Mimoza BodénMBMimoza Bodén
- Therese BlidbergTBTherese Blidberg
- Osman DadasODOsman Dadas
- Jenny MattssonJMJenny Mattsson
Open Access
- 15 October 2026
- other
- Published by American Association for Cancer Research (AACR)